These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31851879)

  • 1. Effects of cotrimoxazole prophylaxis on
    Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H
    Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and Mechanism of Cotrimoxazole Against Talaromyces marneffei in vitro.
    Chen J; Chen R; Wei W; Qin F; Chen X; He J; Zhang H; Wang G; Shi M; Qin T; Liao Y; Wu Y; Lu B; Tao X; Ye L; Liang H; Jiang J
    Mycopathologia; 2022 Dec; 187(5-6):579-593. PubMed ID: 36318375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study.
    Jiang J; Meng S; Huang S; Ruan Y; Lu X; Li JZ; Wu N; Huang J; Xie Z; Liang B; Deng J; Zhou B; Chen X; Ning C; Liao Y; Wei W; Lai J; Ye L; Wu F; Liang H
    Clin Microbiol Infect; 2019 Feb; 25(2):233-241. PubMed ID: 29698815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis.
    Qin Y; Huang X; Chen H; Liu X; Li Y; Hou J; Li A; Yan X; Chen Y
    BMC Infect Dis; 2020 Jul; 20(1):551. PubMed ID: 32727383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.
    Zhu Q; Wang L; Lin W; Bulterys M; Yang W; Sun D; Cui Z; Kaplan J; Kleinman N; Wei X; Chung J; Wang Z
    Curr HIV Res; 2014; 12(5):359-65. PubMed ID: 25426939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design.
    Anywaine Z; Abaasa A; Levin J; Kasirye R; Kamali A; Grosskurth H; Munderi P; Nunn A
    Contemp Clin Trials; 2015 Jul; 43():100-4. PubMed ID: 26009024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and risk factors for readmission in HIV-infected patients with Talaromyces marneffei infection.
    Shi M; Qin Y; Chen S; Wei W; Meng S; Chen X; Li J; Li Y; Chen R; Su J; Yuan Z; Wang G; Qin Y; Ye L; Liang H; Xie Z; Jiang J
    PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011622. PubMed ID: 37816066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy].
    Yang W; Liang Y; Li J; Ma Y; Li N; Sun D; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):689-94. PubMed ID: 25174473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection.
    Sun J; Sun W; Tang Y; Zhang R; Liu L; Shen Y; Wang J; Chen J; Qi T; Wang Z; Song W; Lin Y; Xu S; Lu H
    BMC Infect Dis; 2021 Jun; 21(1):514. PubMed ID: 34074256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study.
    Kasirye R; Grosskurth H; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Baisley K
    Malar J; 2016 Jul; 15():361. PubMed ID: 27417903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
    AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
    Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
    J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: A retrospective study in southern China.
    Wang Y; Mo X; Zhang J; Yan Z; Fang Y; Deng W; Xu J; Peng J; Miao Y
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37553136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Talaromyces marneffei Infection in Human Immunodeficiency Virus-positive and Human Immunodeficiency Virus-negative Patients from Fujian, China.
    Li HR; Cai SX; Chen YS; Yu ME; Xu NL; Xie BS; Lin M; Hu XL
    Chin Med J (Engl); 2016 May; 129(9):1059-65. PubMed ID: 27098791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013.
    Zhang G; Gong Y; Wang Q; Deng L; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
    Medicine (Baltimore); 2016 Jul; 95(27):e3969. PubMed ID: 27399071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
    Dembelu M; Kote M; Gilano G; Mohammed T
    PLoS One; 2021; 16(12):e0261454. PubMed ID: 34972122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination antiretroviral therapy on the clinical manifestations, radiological characteristics, and disease severity of HIV-associated
    Shi X; Yan Q; Zhan Y; Shi C; Song F; Wang L; Qi T; Lu H; Shan F; Shi Y
    Int J STD AIDS; 2020 Jul; 31(8):747-752. PubMed ID: 32631212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China.
    Li YY; Dong RJ; Shrestha S; Upadhyay P; Li HQ; Kuang YQ; Yang XP; Zhang YG
    AIDS Res Ther; 2020 May; 17(1):26. PubMed ID: 32456686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.
    Kasirye RP; Baisley K; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Grosskurth H
    AIDS; 2016 Feb; 30(4):635-44. PubMed ID: 26558729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of HIV-Associated Talaromyces marneffei Infection of Intestine in Southern China.
    Xie Z; Lai J; Peng R; Mou M; Liang H; Ning C
    Int J Infect Dis; 2022 Jul; 120():48-50. PubMed ID: 35398298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.